GleamWall
中文EN

NTRB NutriBand Inc.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1676047 · Fiscal year ends 01/31

Financial factors as of 2026-07-31 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-37.3%
TTM net income YoY32.2%
TTM EPS YoY83.0%
Revenue 3-yr CAGR-10.8%
Net income 3-yr CAGR—

Margins

Gross margin33.1%
Operating margin-435.6%
Net margin-430.4%
FCF margin—
EBITDA margin-426.5%

Returns

ROE-100.7%
ROA-84.6%
ROIC (approx.)-326.9%
Asset turnover0.20x

Leverage & solvency

Liabilities / assets15.3%
Debt / equity0.00x
Current ratio4.21x
Interest coverage-339.35x

Cash quality & payout

Operating cash flow / net income0.52x
Accruals ratio-40.4%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q22026-07-312027Q12026-04-302026Q4*2026-01-312026Q32025-10-312026Q22025-07-312026Q12025-04-302025Q4*2025-01-312025Q32024-10-31
Income statement
Revenue$437,514$433,399$400,709$346,058$622,452$667,432$642,379$645,796
Cost of revenue$255,640$236,598$311,768$277,553$465,571$415,451$356,435$454,767
Gross profit$181,874$196,801$88,941$68,505$156,881$251,981$285,944$191,029
R&D expense$322,194$247,261$188,036$457,113$562,554$683,426$489,856$880,768
SG&A expense$750,317$1.20M$921,820$3.49M$1.60M$982,052$1.76M$737,102
Operating income-$890,637-$1.25M-$1.02M-$3.88M-$2.00M-$1.41M-$5.56M-$1.43M
Interest expense$4,874$5,008$5,334$5,548$5,773$5,880$3,739$4,031
Pretax income-$880,561-$1.24M-$968,059-$3.87M-$2.00M-$1.39M-$5.52M-$1.36M
Net income-$880,561-$1.24M-$968,059-$3.87M-$2.00M-$1.39M-$5.52M-$1.36M
EBITDA-$857,311-$1.22M-$985,036-$3.84M-$1.95M-$1.36M-$5.49M-$1.35M
EPS (basic)-0.07-0.10—-0.32-2.12-0.12—-0.12
EPS (diluted)-0.07-0.10—-0.32-2.12-0.12—-0.12
Weighted avg. shares (diluted)12.16M12.16M—12.06M11.22M11.13M—11.10M
Balance sheet
Cash & equivalents$3.42M$4.01M$4.57M$5.31M$7.00M$2.96M$4.31M$5.70M
Receivables$23,592$2,632$118,404$147,562$160,804$94,136$73,847$109,630
Inventory$170,733$121,494$117,987$135,998$138,031$215,324$212,041$168,299
Current assets$3.82M$4.38M$4.99M$5.82M$7.52M$3.43M$4.79M$6.19M
PP&E, net$530,085$548,244$567,255$587,968$615,857$658,073$695,063$739,630
Goodwill$1.72M$1.72M$1.72M$1.72M$1.72M$1.72M$1.72M$5.02M
Intangibles$170,094$185,261$200,427$215,593$230,760$245,926$261,092$582,418
Total assets$6.29M$6.89M$7.55M$8.42M$10.18M$6.15M$7.47M$12.54M
Current liabilities$907,048$832,137$784,281$772,524$1.57M$925,051$982,845$1.25M
Total liabilities$964,358$902,312$868,447$870,208$1.68M$1.05M$1.04M$1.31M
Shareholders' equity$5.33M$5.99M$6.68M$7.55M$8.49M$5.10M$6.43M$11.23M
Shares outstanding12.16M12.16M12.16M12.17M12.02M11.13M11.07M11.11M
Cash flow statement
Operating cash flow-$584,999-$563,104-$731,830-$1.75M-$1.31M-$1.34M-$1.24M-$1.01M
Capital expenditure——$0$0$0$5,324$0$46,958
Free cash flow——-$731,830-$1.75M-$1.31M-$1.34M-$1.24M-$1.06M
Investing cash flow——$0$0$0-$5,324$0-$46,958
Financing cash flow$430-$5,569-$5,490$69,563$5.34M-$5,324-$147,224-$5,175
Depreciation & amortization$33,326$34,177$35,879$42,956$57,382$57,480$72,855$73,149
Stock-based compensation—$552,458$98,513———$855,600$0

Free plan shows the latest 8 periods; Pro shows all 44 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.